Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General
of the New Zealand Food Safety Authority gives notice
that the following application has been made to register a trade name product under section 9(1) of the Agricultural Compounds and Veterinary Medicines Act 1997:
Trade Name: Porcine Pili Shield
Reference: A010167
Active Ingredient and Concentration: Esherichia coli bacterin (K88, K99, F41 and 987P – all RP= 1.0)
Formulation Type: Aqueous suspension
General Use Claims: For use in healthy pregnant swine as an aid in control of disease in piglets caused by K88, K99, F41 and 987P piliated Escherichia coli.
Any person may make a written submission to the
director-general concerning this application. Under sections 16 and 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
A copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general’s address for service:
ACVM Group, New Zealand Food Safety
Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.
The applicant’s address for service is:
Novartis New Zealand Limited, 6–8 Mackelvie Street, Grey Lynn, Auckland 1021. Postal Address: Private Bag 47909, Ponsonby, Auckland 1144.
Dated at Wellington this 22nd day of September 2008.
MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority).